<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Sanofi-Aventis Cuts Hundreds Of US Sales Reps</title>
	<atom:link href="http://www.pharmalot.com/2008/12/sanofi-aventis-cuts-hundreds-of-us-sales-reps/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/12/sanofi-aventis-cuts-hundreds-of-us-sales-reps/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Sat, 20 Mar 2010 13:12:42 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: SalesStrategist</title>
		<link>http://www.pharmalot.com/2008/12/sanofi-aventis-cuts-hundreds-of-us-sales-reps/#comment-383960</link>
		<dc:creator>SalesStrategist</dc:creator>
		<pubDate>Sun, 07 Dec 2008 16:33:17 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=18224#comment-383960</guid>
		<description>Sanofi-Aventis, like Merck before them has adopted a "New Commercial Model" that uses technology-enabled alternative sales channels linking reps and physicians with live video detailing.  ~40% of physicians are viewed as no-see or hard-to-see but 90%+ are going online to search for medical information.
The potential is obvious, but only recently have some leading pharma marketers recognized that the physician needs to be served on their terms, whenever, wherever they are.  

As the field rep productivity is declining, the industry has to find alternative models, and S-A apparantly has.</description>
		<content:encoded><![CDATA[<p>Sanofi-Aventis, like Merck before them has adopted a &#8220;New Commercial Model&#8221; that uses technology-enabled alternative sales channels linking reps and physicians with live video detailing.  ~40% of physicians are viewed as no-see or hard-to-see but 90%+ are going online to search for medical information.<br />
The potential is obvious, but only recently have some leading pharma marketers recognized that the physician needs to be served on their terms, whenever, wherever they are.  </p>
<p>As the field rep productivity is declining, the industry has to find alternative models, and S-A apparantly has.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
